TUESDAY, Nov. 9, 2021 (HealthDay News) — Young, Black Americans are experiencing significant spikes in obesity, type 2 diabetes and smoking, all risk factors for heart attack and stroke. Between 2007 and 2017 – before the COVID-19 pandemic and the concerns it has created – hospitalized Black Americans aged 18Continue Reading

THURSDAY, Nov. 4, 2021 (HealthDay News) — A urine test might one day be able to tell which prostate cancer patients need immediate treatment and which don’t, British researchers report. “Prostate cancer can be divided into low and high risk — the low-risk men rarely require treatment, and the high-riskContinue Reading

WEDNESDAY, Nov. 3, 2021 (HealthDay News) — Wine lovers, beer drinkers and those who enjoy a martini now and then have long been told that moderate drinking beats total abstinence. Unfortunately, new German research is throwing some cold water on that advice, finding that premature death among non-drinkers is likelyContinue Reading

THURSDAY, Oct. 28, 2021 (HealthDay News) — Younger patients with advanced colon cancer don’t live longer than older patients, but it’s unclear why, researchers say. The authors of the new study said they were surprised by the findings, which come as colon cancer rates are on the rise among youngContinue Reading

WEDNESDAY, Oct. 27, 2021 (HealthDay News) — Anti-vaxxers felt their suspicions confirmed when former U.S. Secretary of State Colin Powell died from COVID-19 complications in mid-October despite being fully vaccinated. But Powell, 84, was being treated for blood cancer at the time of his death, and a new study reportsContinue Reading

WEDNESDAY, Oct. 27, 2021 (HealthDay News) — After prostate cancer surgery, men can safely undergo fewer radiation treatments at higher doses, a new clinical trial shows. Researchers found that the shorter regimen — given over five weeks, instead of seven — did not raise patients’ odds of lasting side effects.Continue Reading

TUESDAY, Oct. 26, 2021 (HealthDay News) — High-dose radiation therapy may stall tumor growth in patients with advanced lung cancer who are not fully responding to drug therapies, a preliminary study suggests. The study involved patients whose lung cancer was considered “oligoprogressive.” That means the cancer had spread to otherContinue Reading